SINGLE NUCLEOTIDE POLYMORPHISM IN IFN WAS ASSOCIATED WITH ACUTE REJECTION AFTER LIVER TRANSPLANTATION

L. Zhou,X. Xu,B. Wei,Z. Zheng,L. Wang,Z. Hu,M. Zhang,S. Zheng
DOI: https://doi.org/10.1016/S0168-8278(13)61018-1
IF: 25.7
2013-01-01
Journal of Hepatology
Abstract:Background and Aims: Kupffer cells activation plays a key role in the pathogenesis of fulminant hepatic failure (FHF).Resolvin D1 (RvD1), an endogenous lipid mediator, display potent properties on switching off and resolving inflammation.In present study, we investigated the role and mechanism of RvD1 in the pathogenesis of FHF induced by Lipopolysaccharide/D-galactosamine (LPS/D-GalN), focusing on Kupffer cell polarization.Methods: C57B/6 mice were pretreated with RvD1 followed by LPS/D-GalN challenge to induce FHF.The mortality was assessed within 48 h, hepatic injury was evaluated by serum aminotransferases activities and hepatic pathological analysis, tumor necrosis factor (TNF)-a was measured by enzyme-linked immunosorbent assay (ELISA), classical (M1) and alternative (M2) macrophage markers were determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR).Results: Pretreatment with RvD1significantly attenuated LPS/D-GalN induced the mortality, hepatic injury, and TNF-a production.Moreover, mice in response to LPS showed an induction of hepatic M1 markers without affecting the M2 markers, RvD1 markedly down-regulated the expression of M1 genes and up-regulated M2 markers.In vitro study with isolated Kupffer cells (KCs) indicated that RvD1 inhibited LPS-induced M1 polarization and promoted Kupffer cells to shift M2 phenotype.Furthermore, KCs depletion by GdCl 3 completely prevented LPS/D-GalN-induced FHF, adoptive transfer of KCs restored the hepatic susceptibility to LPS/D-GalN.However, adoptive transfer of RvD1-primed KCs prevented FHF induced by LPS/D-GalN.Conclusions: These findings indicate that RvD1 has beneficial effects on LPS/D-GalN-induced FHF, which may be mediated by regulating Kupffer cells polarization from M1 to M2, thereby alleviating hepatic pro-inflammatory cytokine production.
What problem does this paper attempt to address?